Beesley VL, Ross TL, King MT, Campbell R, et al. Evaluating patient-reported symptoms and late adverse effects following completion of first-line chemotherapy for ovarian cancer using the MOST (Measure of Ovarian Symptoms and Treatment concerns). Gynecol Oncol 2021 Dec 23. pii: S0090-8258(21)01632.
PMID: 34955238